We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.9B
AUM Growth
-$428M
Cap. Flow
-$938M
Cap. Flow %
-6.29%
Top 10 Hldgs %
21.36%
Holding
1,841
New
125
Increased
760
Reduced
901
Closed
50

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$84.7M
2
AMZN icon
Amazon
AMZN
+$51.3M
3
MSFT icon
Microsoft
MSFT
+$51.2M
4
META icon
Meta Platforms (Facebook)
META
+$26.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.6M

Sector Composition

Rank Sector Weight
1 Technology 19.18%
2 Financials 13.19%
3 Healthcare 12.85%
4 Consumer Discretionary 10.78%
5 Communication Services 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGOV
1651
DELISTED
NIC Inc
EGOV
$165K ﹤0.01%
10,628
+374
+4% +$5.69K
NMIH icon
1652
NMI Holdings
NMIH
$3.16B
$164K ﹤0.01%
+10,084
New +$163K
SFL icon
1653
SFL Corp
SFL
$1.58B
$164K ﹤0.01%
+10,981
New +$161K
DF
1654
DELISTED
Dean Foods Company
DF
$164K ﹤0.01%
15,586
+438
+3% +$4.14K
KALA icon
1655
KALA BIO
KALA
$11.3M
$163K ﹤0.01%
5
SNNA
1656
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$163K ﹤0.01%
10,743
-683
-6% -$11.6K
BEL
1657
DELISTED
Belmond Ltd.
BEL
$162K ﹤0.01%
14,514
+470
+3% +$5.37K
CNSL
1658
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$161K ﹤0.01%
12,990
+1,474
+13% +$17.2K
MXL icon
1659
MaxLinear
MXL
$8.17B
$160K ﹤0.01%
10,238
+479
+5% +$9.68K
NH
1660
DELISTED
NantHealth, Inc
NH
$160K ﹤0.01%
3,222
-252
-7% -$12.5K
FORM icon
1661
FormFactor
FORM
$8.79B
$159K ﹤0.01%
11,990
+538
+5% +$7.29K
NPKI
1662
NPK International
NPKI
$1.22B
$157K ﹤0.01%
14,466
+937
+7% +$9.52K
FG
1663
DELISTED
FGL Holdings Ordinary Shares
FG
$157K ﹤0.01%
+18,681
New +$170K
CRVS icon
1664
Corvus Pharmaceuticals
CRVS
$1.15B
$155K ﹤0.01%
14,095
+3,291
+30% +$36.7K
CRBP icon
1665
Corbus Pharmaceuticals
CRBP
$173M
$154K ﹤0.01%
1,020
-46
-4% -$8.36K
MRNS
1666
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$154K ﹤0.01%
5,456
+783
+17% +$17.4K
RARX
1667
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$154K ﹤0.01%
15,472
-938
-6% -$6.48K
AAMI
1668
Acadian Asset Management
AAMI
$2.86B
$153K ﹤0.01%
+10,758
New +$165K
CYS
1669
DELISTED
CYS Investments Inc.
CYS
$153K ﹤0.01%
20,420
+630
+3% +$4.51K
SCS
1670
DELISTED
Steelcase
SCS
$151K ﹤0.01%
11,179
+398
+4% +$5.64K
PGEN icon
1671
Precigen
PGEN
$1.98B
$150K ﹤0.01%
+10,751
New +$182K
CORI
1672
DELISTED
Corium International, Inc.
CORI
$150K ﹤0.01%
18,712
-591
-3% -$5.59K
IMUX icon
1673
Immunic
IMUX
$195M
$149K ﹤0.01%
55
+6
+12% +$13.9K
FSP
1674
Franklin Street Properties
FSP
$46.1M
$147K ﹤0.01%
17,201
+513
+3% +$4.06K
IRT icon
1675
Independence Realty Trust
IRT
$3.87B
$147K ﹤0.01%
14,302
+945
+7% +$9.1K

Similar funds

ProShare Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, ProShare Advisors held 1,841 positions worth $14.9B, down 2.8% from $15.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors withdrew a net $938M in Q2 2018, closing 50 positions and reducing 901 holdings. Its most notable exit was Monsanto Co, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ProShare Advisors opened a new position in First of Long Island Corp worth $6.18M.

  • ProShare Advisors's largest Q2 2018 buy was First of Long Island Corp: 248,853 shares worth $6.18M.
  • ProShare Advisors added most to Walgreens Boots Alliance in Q2 2018, an estimated $15M increase.
  • ProShare Advisors's biggest Q2 2018 reduction was Apple, cutting an estimated $84.7M.
  • ProShare Advisors fully exited Monsanto Co in Q2 2018, selling an estimated $11.2M.
  • ProShare Advisors's ten largest holdings make up 21% of its $14.9B portfolio in Q2 2018.
  • ProShare Advisors opened 125 new positions and closed 50 in Q2 2018.
  • ProShare Advisors's portfolio value fell 2.8% quarter-over-quarter to $14.9B.

Based on ProShare Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.